Aim & Scope
EMBO Molecular Medicine is a peer-reviewed, online open access journal dedicated to a new research discipline at the interface between clinical research and basic biology. It offers clinicians and researchers in this area the opportunity to publish their best work in a broadly distributed and highly visible forum, thereby lending a strong impetus to this important and rapidly developing field and helping to forge new links between clinicians and molecular biologists. Studies based on model organisms also fall within the scope of the journal, provided that the results presented are evidently and directly relevant to human disease. EMBO Molecular Medicine publishes research articles as full-length research papers and short reports. In addition, the journal publishes editorials and review articles in innovative formats that target a broad and non-specialized audience. Areas within the scope include, but are not limited to: Aging; Angiogenesis; Cancer biology; Channelopathies; Differentiation and development; Endocrinology/Metabolic disease; Genetics/epigenetics; Genomics, transcriptomics, proteomics, metabolomics of disease, systems medicine; Gene therapy; Immunology and inflammation; Infectious diseases; Neurodegeneration, neurological diseases and myopathies, sensory defects; Stem cells and regenerative medicine; Vascular and cardiovascular biology. [1]
Series / Collection
0261-4189 ( Print )
1460-2075 ( Online )
EMBO Press
,
European Molecular Biology Organization (EMBO)
,
Nature Research
,
Wiley
,
Wiley-VCH
EMBO Molecular Medicine
1757-4676 ( Print )
1757-4684 ( Online )
EMBO Press
,
European Molecular Biology Organization (EMBO)
,
Wiley
1469-221X ( Print )
1469-3178 ( Online )
EMBO Press
,
European Molecular Biology Organization (EMBO)
,
Nature Research
,
Wiley
,
Wiley-VCH
2575-1077 ( Online )
EMBO Press
,
Cold Spring Harbor Laboratory Press
,
Life Science Alliance
,
Rockefeller University Press
1744-4292 ( Online )
EMBO Press
,
European Molecular Biology Organization (EMBO)
,
Nature Research
,
Wiley
,
Wiley-VCH
2024
Platelet transcription factors license the pro-inflammatory cytokine response of human monocytes
I Hawwari , L Rossnagel , N Rosero , ... , BS Franklin
EMBO Molecular Medicine , 2024
0
90
Immune-enhancing neutrophils reprogrammed by subclinical low-dose endotoxin in cancer treatment
Y Zhang , C Lee , S Geng , ... , L Li
EMBO Molecular Medicine , 2024
0
43
In vitro and in vivo inhibition of the host TRPC4 channel attenuates Zika virus infection
X Chen , Y Yan , Z Liu , ... , W Zhong
EMBO Molecular Medicine , 2024
0
50
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer.
Y Tai , A Chow , S Han , ... , S Acharyya
EMBO Molecular Medicine , 2024
0
89
LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis
J Wang , Q Chai , Z Lei , ... , CH Liu
EMBO Molecular Medicine , 2024
0
70
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets
L Chocarro , E Blanco , L Fernandez-Rubio , ... , D Escors
EMBO Molecular Medicine , 2024
0
76
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells
J Rich , M Bennaroch , L Notel , ... , I Pirozhkova
EMBO Molecular Medicine , 2024
0
193
Editorial Retractions, Expressions of Concern and External Notices
Cysteamine-bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis.
A Jamalpoor , CA van Gelder , FA Yousef Yengej , ... , MJ Janssen
EMBO Molecular Medicine2021 - VOLUME 13, ISSUE 7 p e13067.
16 71
B Dejanovic , T Djémié , N Grünewald , ... , G Schwarz
EMBO Molecular Medicine2015 - VOLUME 7, ISSUE 12 pp 1580-1594.
24 56
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.
G Zadra , C Photopoulos , S Tyekucheva , ... , M Loda
EMBO Molecular Medicine2014 - VOLUME 6, ISSUE 4 pp 519-538.
119 72
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.
M Sonego , M Schiappacassi , S Lovisa , ... , G Baldassarre
EMBO Molecular Medicine2013 - VOLUME 5, ISSUE 5 pp 707-722.
36 48
Pseudocercospora Boehmeriigena
PubPeer
2023 - VOLUME 2023, ISSUE 9
0 0
J Jia , TM Conlon , RS Sarker , ... , AÖ Yildirim
EMBO Molecular Medicine2018 - VOLUME 10, ISSUE 5 p e8349.
33 71
O Koltsida , S Karamnov , K Pyrillou , ... , E Andreakos
EMBO Molecular Medicine2013 - VOLUME 5, ISSUE 5 pp 762-775.
35 66
SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models.
OC Kwon , JJ Song , Y Yang , ... , SH Lee
EMBO Molecular Medicine2021 - VOLUME 13, ISSUE 4 p e13076.
38 127
Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy.
P Bella , A Farini , S Banfi , ... , Y Torrente
EMBO Molecular Medicine2020 - VOLUME 12, ISSUE 1 p e11019.
14 79
Long non-coding RNA MALAT1 regulates retinal neurodegeneration through CREB signaling.
J Yao , XQ Wang , YJ Li , ... , B Yan
EMBO Molecular Medicine2016 - VOLUME 8, ISSUE 4 pp 346-362.
60 51
J Yao , XQ Wang , YJ Li , ... , B Yan
EMBO Molecular Medicine
2022 - VOLUME 14, ISSUE 12
4 1